{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:17:07Z","timestamp":1790806627851,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.diabres.2022.109840","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T03:03:05Z","timestamp":1647831785000},"page":"109840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry"],"prefix":"10.1016","volume":"186","author":[{"given":"Hitoshi","family":"Ide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Ohkuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Komorita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udai","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109840_b0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.diabres.2022.109840_b0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db16-0796","article-title":"Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease","volume":"66","author":"Gilbert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109840_b0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1159\/000189149","article-title":"Measures of tubular function in normoalbuminuric insulin-dependent diabetic patients and their relationship with sodium lithium countertransport activity","volume":"73","author":"Catalano","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.diabres.2022.109840_b0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","article-title":"The promise of tubule biomarkers in kidney disease: a review","volume":"78","author":"Ix","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2022.109840_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20420188211049612","article-title":"Current updates on protein as biomarkers for diabetic kidney disease: a systematic review","volume":"12","author":"Sauriasari","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2022.109840_b0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2022.109840_b0035","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jdi.12977","article-title":"Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014","volume":"10","author":"Kume","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2022.109840_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.661185","article-title":"Current challenges and future perspectives of renal tubular dysfunction in diabetic kidney disease","volume":"12","author":"Duan","year":"2021","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.diabres.2022.109840_b0045","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2215\/CJN.02590315","article-title":"Urinary biomarkers and risk of ESRD in the Atherosclerosis Risk in Communities Study","volume":"10","author":"Foster","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109840_b0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00125-014-3389-3","article-title":"Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus","volume":"58","author":"Fufaa","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109840_b0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","article-title":"Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression","volume":"91","author":"Hsu","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2022.109840_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide epidemiology of diabetes-related end-stage renal disease, 2000\u20132015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109840_b0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/dc12-0904","article-title":"Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry","volume":"36","author":"Ohkuma","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2022.109840_b0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.diabres.2022.109840_b0075","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s10157-018-1615-x","article-title":"Guidelines for clinical evaluation of chronic kidney disease\u202f: AMED research on regulatory science of pharmaceuticals and medical devices","volume":"22","author":"Kanda","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109840_b0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10157-021-02136-2","article-title":"Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry","volume":"26","author":"Iwase","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.diabres.2022.109840_b0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ndt\/gft510","article-title":"A basic science view of acute kidney injury biomarkers","volume":"29","author":"Charlton","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.diabres.2022.109840_b0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diabres.2012.02.007","article-title":"Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients","volume":"97","author":"Nielsen","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.109840_b0095","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.kint.2017.11.024","article-title":"Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development","volume":"93","author":"Nowak","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2022.109840_b0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jdiacomp.2019.05.013","article-title":"Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: a prospective cohort study","volume":"33","author":"Satirapoj","year":"2019","journal-title":"J Diabetes Complications"},{"issue":"10","key":"10.1016\/j.diabres.2022.109840_b0105","doi-asserted-by":"crossref","first-page":"107665","DOI":"10.1016\/j.jdiacomp.2020.107665","article-title":"Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease","volume":"34","author":"Duan","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.diabres.2022.109840_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2020.07.011","article-title":"Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"77","author":"Anderson","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.diabres.2022.109840_b0115","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0002-9440(10)63384-6","article-title":"Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules","volume":"165","author":"Kamijo","year":"2004","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.diabres.2022.109840_b0120","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/dc12-1298","article-title":"Predictive effects of urinary liver-type fatty acid\u2013binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy","volume":"36","author":"Araki","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109840_b0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/dc10-1392","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients","volume":"34","author":"Kamijo-Ikemori","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109840_b0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.clinbiochem.2015.10.016","article-title":"Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes","volume":"49","author":"de Carvalho","year":"2016","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.diabres.2022.109840_b0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/0886022X.2019.1617736","article-title":"Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies","volume":"41","author":"Tang","year":"2019","journal-title":"Ren Fail"},{"issue":"2","key":"10.1016\/j.diabres.2022.109840_b0140","doi-asserted-by":"crossref","first-page":"107479","DOI":"10.1016\/j.jdiacomp.2019.107479","article-title":"Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients","volume":"34","author":"Milas","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.diabres.2022.109840_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13098-017-0228-y","article-title":"Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus","volume":"9","author":"Petrica","year":"2017","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.diabres.2022.109840_b0150","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"de Boer","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2022.109840_b0155","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/dom.13301","article-title":"Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:22:28Z","timestamp":1759173748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722006520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"alternative-id":["S0168822722006520"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109840","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109840"}}